RIBOBODY Trademark
Trademark Overview
On Friday, June 28, 2024, a trademark application was filed for RIBOBODY with the United States Patent and Trademark Office. The USPTO has given the RIBOBODY trademark a serial number of 98623781. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, May 26, 2026. This trademark is owned by Ribo Therapeutics Inc.. The RIBOBODY trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical, therapeutic pharmaceuticals, and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, RNA-based therapeutic pharmaceuticals and therapeutic agents for the treatment of a variety of human and animal diseases and disorders; medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of human and animal diseases and disorders
Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; custom RNA targeting and assay development for the treatment of a variety of human and animal diseases and disorders in the field of biotechnology; pharmaceutical drug development related to proteins, ribosomes, DNA and RNA
Chemicals for use in therapeutic product development and manufacturing processes in the medical field; Biological and chemical agents, namely, chemical preparations for scientific and research use; chemicals for use in biotherapeutics in the biochemical and chemical industries and excluding medical and veterinary purpose; biological preparations for use in industry and science; chemical agents, namely, chemical preparations for analyses in laboratories, other than for medical or veterinary purposes
General Information
| Serial Number | 98623781 |
| Word Mark | RIBOBODY |
| Filing Date | Friday, June 28, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 7, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical, therapeutic pharmaceuticals, and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, RNA-based therapeutic pharmaceuticals and therapeutic agents for the treatment of a variety of human and animal diseases and disorders; medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of human and animal diseases and disorders |
| Goods and Services | Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; custom RNA targeting and assay development for the treatment of a variety of human and animal diseases and disorders in the field of biotechnology; pharmaceutical drug development related to proteins, ribosomes, DNA and RNA |
| Goods and Services | Chemicals for use in therapeutic product development and manufacturing processes in the medical field; Biological and chemical agents, namely, chemical preparations for scientific and research use; chemicals for use in biotherapeutics in the biochemical and chemical industries and excluding medical and veterinary purpose; biological preparations for use in industry and science; chemical agents, namely, chemical preparations for analyses in laboratories, other than for medical or veterinary purposes |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 28, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 28, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 28, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Ribo Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036
US |
| Party Name | Ribo Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036
US |
Trademark Events
| Event Date | Event Description |
| Friday, June 28, 2024 | NEW APPLICATION ENTERED |
| Wednesday, January 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 23, 2025 | ASSIGNED TO EXAMINER |
| Friday, February 28, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, February 28, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, February 28, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 28, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, May 28, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, August 28, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 28, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 28, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 4, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 1, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 7, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 7, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 2, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 26, 2026 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 26, 2026 | SOU EXTENSION 1 FILED |
| Tuesday, May 26, 2026 | SOU EXTENSION 1 GRANTED |
| Wednesday, May 27, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
